Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 465 for “"Lewy"”.
-
Role Of Endogenous Tau In Lewy-Like Pathology
Lewy Body Diseases (LBDs) are a group of disorders characterized by intracellular inclusions of misfolded alpha-synuclein (α-synuclein). Of these, Parkinson’s Disease (PD) is the most common neurodegenerative movement disorder, and Dementia with Lewy Bodies (DLB) is the second most common …
-
Inflammation in Dementia with Lewy bodies and Alzheimer’s disease
Dementia with Lewy bodies (DLB) is the second most common neurodegenerative cause of dementia. However, the aetiology of DLB remains poorly understood in comparison with Alzheimer’s disease (AD) and Parkinson’s disease (PD). Current evidence supports that neuroinflammation, with involvement of the …
-
Cognitive impairment in lewy body diseases: treatments and assessments
… implications of pharmacological treatments for Lewy body diseases (LBD), alongside cognitive profiling and remote assessment methodologies. A network meta-analysis of 22 randomised controlled trials, involving over 3300 patients with Parkinson’s disease dementia (PDD) and dementia with Lewy …
-
Dementia with Lewy bodies - a clinical and neurological approach
Dementia with Lewy bodies (DLB) is a dementia disorder, clinically characterized by fluctuating cognitive impairment, attention deficits, visual hallucinations, parkinsonism and other neuropsychiatric features. Sensitivity to neuroleptic medication is a common finding. In the present study 24% of …
-
Cerebrovascular contributions to Lewy body diseases and associated disorders
Parkinson’s disease (PD) and dementia with Lewy bodies (DLB) are characterised by the abnormal accumulation of a protein known as a-synuclein. This protein aggregates to form Lewy bodies and Lewy neurites in specific brain regions. A major research focus is on understanding why a-synuclein …
-
Identifying Factors That Modulate Neuronal Subtype Vulnerability To Lewy Pathology
… the protein α-synuclein (α-syn), known as Lewy pathology (LP), characterize the age-related neurodegenerative disorders termed synucleinopathies, the most prevalent being Parkinson’s disease (PD). The motor and non-motor symptoms that define PD correlate closely with neuronal dysfunction …
-
Living with Lewy body dementia. Treatment, survival & quality of life.
Background: Patients with Lewy body dementias (LBD) have a complex clinical picture. With no prevention or cure, management focuses around symptomatic relief, however pharmacological and non-pharmacological options have been inadequately investigated. Moreover, the understanding of survival, …
-
Dementia with Lewy bodies —an Investigation of Cause and Consequence
Dementia with Lewy bodies (DLB) is today considered to be the second most common primary neurodegenerative dementia after Alzheimer’s disease. However, the disease has only been a clearly defined entity for 13 years. Due to its recent recognition, DLB is still not as extensively studied as are …
-
The profile of cerebral T cells in dementia with Lewy bodies
Dementia with Lewy bodies (DLB) is the second most common neurodegenerative cause of dementia, behind Alzheimer’s disease (AD). Neuroinflammation has been implicated in the aetiology of AD, with the involvement of both innate and adaptive immune responses. A potential role for adaptive immune cells …
-
Investigating molecular mechanisms behind neuronotypic GBA1 mutations in Lewy body dementias
… mechanistic role of GBA1L444P expression in Lewy body dementias. This was accomplished by addressing two questions: 1) how does GBA1L444P expression contribute to the phenotypes in GBA1-associated Parkinson’s disease (Chap-ter 2)? And 2) what contributes to the cortical-hippocampal-dependent …
-
THE EFFECT OF NOVEL MICROTUBULE MODULATORS ON EXPERIMENTAL LEWY BODY DISEASE
In Lewy body disorders, α-synuclein aggregates are believed to destabilize the microtubular framework. However, microtubules are a challenging therapeutic target, as excessive rigidity or flexibility afforded by microtubule modulators may be neurotoxic. Thus, the objective of the present study was …
-
Astrocytic diazepam binding inhibitor instructs microglial synaptic engulfment in Lewy body dementia
In Lewy body dementia (LBD), loss of synapses is associated with reactive astrocytes and activated microglia. However, the interaction between these two major glial cell types and the subsequent implications on synaptic removal remain unclear. This study demonstrates that anomalous secretion of …
-
Structure and function of α-synuclein fibril polymorphs in Lewy body dementia
… multiple system atrophy (MSA), and dementia with Lewy bodies (DLB). α-Syn fibrils have the propensity to propagate and form cytoplasmic deposits in a prion-like manner. Intracranial injections of synucleinopathy-affected brain extracts containing α-syn fibrils into the model mice initiate the …
-
Anatomy of visual hallucinations and fluctuations of consciousness in Lewy body diseases
Lewy body diseases are characterized by parkinsonian disorders of movement and neuropsychiatric features of dementia, visual hallucinations and altered states of consciousness. The underlying neurobiological changes responsible for the psychiatric features are poorly understood. The integrative …
-
Executive functioning in mild cognitive impairment, frontotemporal dementia, and Lewy body dementia
… disease), frontotemporal dementia (FTD), and Lewy body dementia (LBD). This thesis contains two papers addressing executive functioning in these patient groups, the first comparing MCI patients to normal controls and the second comparing FTD and LBD patients. In each study, we examined …
-
Differentiating Gait Behaviors between Early-Stage Dementia with Lewy Bodies and Parkinson’s Disease
Dementia with Lewy bodies (DLB) and Parkinson’s disease (PD) can be difficult to differentially diagnose, given the overlap in clinical and pathological features. Evidence suggests gait may be a sensitive and selective marker of neurodegeneration. The complexity of the behavior combined with the …
-
Development of a novel viral vector-based mouse model for Lewy Body dementia
Abstract not currently available.
-
Sex-specific Effects of Chaperone and Glial Defenses on Experimental Lewy Body Disease
Lewy body disorders are a group of neurodegenerative conditions characterized by the pathological misfolding and aggregation of the abundant protein, α-synuclein. The most common Lewy body disorders are Parkinson’s disease and dementia with Lewy bodies. Apart from ageing, male sex is a major risk …
Page 1 of 24